18th Aug 2020 17:43
OKYO Pharma Ltd - London-based biopharmaceutical company - Raises GBP1.4 million through issue of convertible loan notes in addition to GBP3.5 million raised in July. Notes have an interest rate of 2.15%, have a maximum term of 4 years and convert into shares at 8.5p each. Proceeds will be used to further the development of its clinical pipeline.
Okyo says it has now raised GBP5.4 million since March-end. Adds it intends to progress a dual listing of its shares on NASDAQ.
Current stock price: 17.00 pence
Year-to-date change: up ten-fold from 1.70p
By Ife Taiwo; [email protected]
Copyright 2020 Alliance News Limited. All Rights Reserved.
Related Shares:
OKYO.L